Thus, additional experiments were used to investigate whether PV-1 combined with anti-PD-1 antibody could enhance the anti-tumor effects of anti-PD-1 antibody, at least partially through g-MDSC inhibition of T cells. This evidence concerns the gene PLVAP and neoplasm.